Diabetes Mellitus, Type 2: all 9,590 studies
Page 63 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Effect of Yakult Ingestion on Diet-induced Insulin Resistance in HumansCompletedNCT03037918Not applicable
- Healthy Eating and Active Living for Diabetes: Glycemic IndexCompletedNCT03037099Not applicable
- DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus PatientsCompletedNCT03033433Phase 1
- Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin TherapyCompletedNCT03030300Phase 4
- Empagliflozin in Heart Failure: Diuretic and Cardio-Renal EffectsCompletedNCT03027960Phase 1
- Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)Status unknownNCT03025919
- Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)Status unknownNCT03024788
- Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real LifeTerminatedNCT03020264Not applicable
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or ObeseStatus unknownNCT03018665Phase 4
- The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 SecretionCompletedNCT03018444Not applicable
- Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.Status unknownNCT03016910
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes MellitusWithdrawnNCT03015519Phase 3
- Episodic to Real-Time Care in Diabetes Self-ManagementCompletedNCT03012074Not applicable
- The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy.Status unknownNCT03010241Early Phase 1
- Empowerment, Motivation and Medical Adherence (EMMA).WithdrawnNCT03008395Not applicable
- The Assessment of the Effect of Vitamin D Supplementation on Inflammatory and Endothelial Factors in the Patients With Type 2 Diabetes .Status unknownNCT03008057Phase 2/3
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.CompletedNCT03007329Phase 4
- Magnesium Supplementation in Type II DiabetesCompletedNCT03002545Not applicable
- Boosting Emotions & Happiness in Outpatients Living With Diabetes: Phase ICompletedNCT03001999Not applicable
- Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Patients With Type 2 DiabetesCompletedNCT02999867Not applicable
- Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownNCT02999841Phase 4
- Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 DiabetesStatus unknownNCT02998970Phase 4
- Effects of Acute High Intensity Exercise Training on Cardiac Function in Type II DiabetesTerminatedNCT02998008Not applicable
- Shift Work, Heredity, Insulin, and Food Timing StudyCompletedNCT02997319
- Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsCompletedNCT02996539
- Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 InhibitorsCompletedNCT02993614
- mHealth for Diabetes Adherence SupportCompletedNCT02990299Not applicable
- Measuring Patient Engagement in Diabetes CareWithdrawnNCT02988427
- Improving Glucose and Lipid Metabolism Through Caloric Restriction Using Diet or Surgery (CRUDOS)Status unknownNCT02988011Not applicable
- A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes PatientsCompletedNCT02987751Phase 4
- Clinical Outcomes of Exenatide Versus Basal InsulinCompletedNCT02987348
- Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular EdemaTerminatedNCT02985242Phase 4
- 1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes MellitusCompletedNCT02985099Phase 2/3
- Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 DiabetesStatus unknownNCT02984605Not applicable
- Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?CompletedNCT02983214Phase 4
- Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 DiabetesCompletedNCT02982408Not applicable
- Impact of a Low Carbohydrate Breakfast on Glucose Control in Type 2 DiabetesCompletedNCT02982330Not applicable
- Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes RiskCompletedNCT02979860Not applicable
- Effect of a Plant Rich Diet on in People With Type 2 Diabetes and ObesityWithdrawnNCT02977039Not applicable
- Glooko mHealth Advantage StudyCompletedNCT02974816Not applicable
- Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to HumansStatus unknownNCT02974699Early Phase 1
- Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)CompletedNCT02974504Phase 4
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal InsulinsCompletedNCT02974244
- Effect of Manual Medicine or Cognitive Behavioral Therapy With Chronic Uncontrolled DiabetesCompletedNCT02971865Not applicable
- Study With DapagliflozinCompletedNCT02971618
- Intergenerational mHealth Diabetes Program OPPORTUNITIES PROGRAM IN TAIWANCompletedNCT02971241Not applicable
- Therapy of Obesity and Diabetes Mellitus Type 2CompletedNCT02970838Not applicable
- Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentCompletedNCT02967237Phase 4
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinCompletedNCT02967224Phase 4
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCompletedNCT02967211Phase 4
- A Real World Experience of Dapagliflozin in Type 2 DiabetesCompletedNCT02966626
- Dapagliflozin + Saxagliptin in a Basal-bolus Insulin TreatmentTerminatedNCT02965443Phase 4
- The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 DiabetesStatus unknownNCT02964715Phase 4
- Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 DiabetesCompletedNCT02964572Not applicable
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 DiabetesCompletedNCT02964104Phase 1
- Format of Patient Education for Different Sociodemographic GroupsStatus unknownNCT02961517
- Social Incentives to Improve DiabetesCompletedNCT02961192Not applicable
- Mitochondrial Effects of C18:0 Supplementation in HumansCompletedNCT02957838Not applicable
- Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?CompletedNCT02956811Phase 4
- Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic PatientsStatus unknownNCT02956655Not applicable
- Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over TimeCompletedNCT02956577
- Pharmaceutical Care Service in DiabetesCompletedNCT02955875Not applicable
- Latinos Understanding the Need for AdherenceCompletedNCT02955238Not applicable
- A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in TurkeyCompletedNCT02954692Phase 4
- The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activationCompletedNCT02951260Not applicable
- Prevention of Type 2 Diabetes Amongst South Asians With Central Obesity and PrediabetesCompletedNCT02949739Not applicable
- Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 DiabetesCompletedNCT02949193Phase 3
- Enhancing mHealth Technology to Activate Chronic Care PatientsCompletedNCT02949037Not applicable
- The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute ExerciseCompletedNCT02948673Not applicable
- Polyneuropathy in Diabetes Mellitus Type 2CompletedNCT02947828
- Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)CompletedNCT02947620Phase 3
- Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 DiabetesStatus unknownNCT02946632Phase 3
- A Clinical Trial to Investigate the Efficacy and Safety of EvogliptinCompletedNCT02946541Phase 3
- Safety of Wharton Jelly in Erectile DysfunctionCompletedNCT02945449Phase 1
- A Study of LY3209590 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT02942914Phase 1
- The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes MellitusWithdrawnNCT02942056Phase 2
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During RamadanCompletedNCT02941367Phase 4
- A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and MetoprololCompletedNCT02940379Phase 1
- Changes of Diet, Physical Activity and Sleep Pattern and Their Effects on Glycemic and Weight Control in Hong Kong Chinese Obese Patients With Type 2 Diabetes After Bariatric Surgery Compared to Telephone Intensive Lifestyle CounsellingCompletedNCT02938026Not applicable
- Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic PatientsCompletedNCT02937987
- Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)CompletedNCT02935712Phase 1
- A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusCompletedNCT02933853Phase 1
- Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM PatientsStatus unknownNCT02933788Phase 4
- Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 DiabeticsCompletedNCT02932436Phase 4
- The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 DiabetesCompletedNCT02929901Phase 2/3
- Integration of Guidelines for ComorbiditiesStatus unknownNCT02928666Not applicable
- Effect of Anti-diabetic Drugs on Glycemic VariabilityCompletedNCT02925559Phase 4
- Effect of Ginseng in Type 2 DiabetesCompletedNCT02923453Phase 2
- Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT02920801Phase 4
- Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial ArteryCompletedNCT02919345Phase 4
- Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.Status unknownNCT02919059Phase 4
- Cardiovascular Effects of EmpagliflozineStatus unknownNCT02918591Not applicable
- Assessing Health Outcomes in Low-income Diabetics Who Receive Monthly Boxes of Healthy Food at ClinicCompletedNCT02917902Not applicable
- Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal ImpairmentCompletedNCT02917057
- A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 DiabetesCompletedNCT02915250Phase 1
- Providing Preventive Periodontal Treatment to Hospitalized Patients With DiabetesCompletedNCT02914743Not applicable
- Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 DiabetesCompletedNCT02914691Phase 4
- Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 DiabetesCompletedNCT02910141
- Whey Protein Effect on Glycaemic and Appetite Responses in T2DStatus unknownNCT02903199Not applicable
- Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 DiabetesStatus unknownNCT02900417Not applicable